| FZANX | RGEBX | FZANX / RGEBX | |
| Total Expense Ratio | 0.70 | 1.08 | 65% |
| Annual Report Gross Expense Ratio | 0.70 | 1.08 | 65% |
| Fund Existence | 13 years | 12 years | - |
| Gain YTD | 7.325 | 5.309 | 138% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 250 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 26.7B | 357B | 7% |
| Annual Yield % from dividends | 0.00 | 0.00 | - |
| Returns for 1 year | 5.65 | 0.66 | 855% |
| Returns for 3 years | 57.45 | 32.78 | 175% |
| Returns for 5 years | 23.51 | 9.78 | 240% |
| Returns for 10 years | 93.46 | 90.83 | 103% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| BRUMX | 19.08 | 0.06 | +0.32% |
| MFS Blended Research Value Equity R4 | |||
| FHLSX | 11.66 | 0.01 | +0.09% |
| Fidelity Health Savings | |||
| FMCEX | 42.38 | 0.03 | +0.07% |
| Fidelity Advisor Stock Selec Mid Cp C | |||
| TRMCX | 38.65 | -0.13 | -0.34% |
| T. Rowe Price Mid-Cap Value | |||
| SICNX | 16.98 | -0.07 | -0.41% |
| Schwab® International Core Equity | |||